Belotero Revive 1 x 1ml
The new hyaluronic acid (HA) filler works beneath the skin to improve skin hydration, reduce redness and roughness and minimize the appearance of fine lines.
Belotero Revive is applied via injection over multiple treatments working as a beauty booster and for an overall youthful radiance. It works beneath the skin to:
- Provide hydration
- Reduce the appearance of fine lines
- As a preventative and early aesthetic intervention treatment to slow the progression of facial changes over time.
Clinic study and tests
4 Belotero Revive was clinically assessed in a study involving 24 patients. Belotero Revive was injected into the lower cheek area of the face the treatment options have been tested in an observation period of over 36 weeks.
- Cross-linked Hyaluronic Acid
- Glycerol 17.5 mg/ml
- Phosphate buffer pH 7 q.s.: 1 ml
Aplication and features
BELOTERO Revive is applied by injection to work beneath the skin. Here it provides direct hydration, thanks to the hyaluron and glycerol it contains. Prevention always beats a cure, which is why hyaluronic acid and glycerol helps with:
- Limit wrinkle formation
- Hydrate the skin
- Redefine the skin structure, for a younger, more radiant look.
It does all this without drastic volume changes, but with a natural flair that keeps you selfie-ready at every instant! As a beauty booster, BELOTERO Revive can be injected over multiple treatments, giving you a youthful radiance from the inside out.
Aesthetic – Merz Pharma
Customer research and market trends on hyaluronic acid
Latest market researches make it clear that a new generation of patients is increasingly open to aesthetic medicine and actively looking for options to treat the first visible signs of aging.
Merz, a global leader in medical aesthetics, announced a few months ago the launch of Belotero Revive, a dermal filler product containing a unique combination of hyaluronic acid (HA) and glycerol, designed to improve hydration, elasticity and firmness of the skin and to address the appearance of fine lines. The newest addition to the Belotero dermal filler range, Belotero Revive was designed to meet the unique needs of today’s aesthetic patients.
Modern consumers are especially focused on skin quality and on minimizing early signs of aging and they value skincare and aesthetic solutions that deliver natural-looking results, – the so-called “no-filter” look.
“We continue to see a growing interest in effective, high quality injectable treatments from a new generation of aesthetic patients, due in part to the influence of social media and other digital channels,” stated Prof. Dr. Martina Kerscher, Professor of Dermatology, University of Hamburg and lead author of the BELOVE study. “Strong scientific research forms the basis for this new dermal injectable and our study results show that treatment with this beauty booster is a an effective way to provide direct skin hydration and increase skin smoothness, giving our patients beautiful, natural-looking results.”
The new Belotero Revive campaign encourages consumers to “Show off the best version of yourself, without a filter!” The campaign hints playfully at the influence of the digital sphere on real-life moments and is designed to speak to the growing acceptance of aesthetic medicine in different age groups, while encouraging female consumers to make choices that bring out their own individual and natural beauty.
Merz, the manufacturer of Belotero Revive
“Customer research and market trends make it clear that a new generation of patients is increasingly open to aesthetic medicine and actively looking for options to treat the first visible signs of aging,” stated Philip Burchard, CEO of Merz. “At Merz, we have a strong focus on researching and developing innovative and effective solutions that can be used to address both specific patient needs and new market trends in medical aesthetics. With Belotero Revive, we are proud to be able to provide aesthetic physicians with a new dermal injectable that can be used for both early intervention and beautification, to help meet the unique needs of individual patients.”